Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016

SA Kozek-Langenecker, AB Ahmed… - European Journal of …, 2017 - journals.lww.com
The management of perioperative bleeding involves multiple assessments and strategies to
ensure appropriate patient care. Initially, it is important to identify those patients with an …

Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder

EJ Favaloro - Seminars in thrombosis and hemostasis, 2011 - thieme-connect.com
ABSTRACT von Willebrand disease (VWD) is the most common inherited bleeding disorder
and arises from deficiencies and/or defects in the plasma protein von Willebrand factor …

Von Willebrand disease mutation spectrum and associated mutation mechanisms

A de Jong, J Eikenboom - Thrombosis research, 2017 - Elsevier
Von Willebrand disease (VWD) is a bleeding disorder that is mainly caused by mutations in
the multimeric protein von Willebrand factor (VWF). These mutations may lead to …

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

AB Federici, P Bucciarelli, G Castaman… - Blood, The Journal …, 2014 - ashpublications.org
Analyses of the bleeding tendency by means of the bleeding score (BS) have been
proposed until now to confirm diagnosis but not to predict clinical outcomes in patients with …

Von Willebrand disease epidemiology, burden of illness and management: a systematic review

P Du, A Bergamasco, Y Moride… - Journal of Blood …, 2023 - Taylor & Francis
Introduction Although hereditary von Willebrand disease (VWD) is the most common
bleeding disorder, its epidemiology is not well understood. A systematic review …

Evaluating errors in the laboratory identification of von Willebrand disease in the real world

EJ Favaloro, RA Bonar, M Meiring, E Duncan… - Thrombosis …, 2014 - Elsevier
Introduction von Willebrand disease (VWD), reportedly the most common bleeding disorder,
arises from deficiency and/or defects of von Willebrand factor (VWF). Assessment requires a …

Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm

J Batlle, A Pérez-Rodríguez, I Corrales… - Thrombosis and …, 2016 - thieme-connect.com
The diagnosis of von Willebrand disease (VWD) remains difficult in a significant proportion
of patients. A Spanish multicentre study investigated a cohort of 556 patients from 330 …

[HTML][HTML] A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand …

F Peyvandi, G Castaman, P Gresele… - Blood …, 2019 - ncbi.nlm.nih.gov
Background There is a lack of prospective clinical trials specifically designed to evaluate the
benefits of prophylaxis with vWF/FVIII concentrates in patients with inherited von Willebrand …

Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2

O Seidizadeh, L Baronciani, MT Pagliari… - Blood …, 2022 - ashpublications.org
Abstract von Willebrand disease (VWD) type 2 is caused by qualitative abnormalities of von
Willebrand factor (VWF). This study aimed to determine the genotypic and phenotypic …

[HTML][HTML] Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy

A Rocino, A Coppola, M Franchini, G Castaman… - Blood …, 2014 - ncbi.nlm.nih.gov
Patients with congenital bleeding disorders (CBD) in Italy are regularly followed by 52
Haemophilia Treatment Centres (HTCs) distributed throughout the country1. The expertise …